The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 06, 2021
Filed:
Apr. 24, 2020
Neurobiogen Co., Ltd., Seongnam-si, KR;
Ki Duk Park, Seoul, KR;
ChangJoon Justin Lee, Seoul, KR;
Dong Jin Kim, Seoul, KR;
Ae Nim Pae, Seoul, KR;
Hyun Ah Choo, Seoul, KR;
Sun Joon Min, Seoul, KR;
Yong Koo Kang, Seoul, KR;
Yun Kyung Kim, Seoul, KR;
Hyo Jung Song, Seoul, KR;
Ji Won Choi, Seoul, KR;
Min Ho Nam, Seoul, KR;
Jun Young Heo, Seoul, KR;
Seul Ki Yeon, Seoul, KR;
Bo Ko Jang, Seoul, KR;
Eun Ji Ju, Seoul, KR;
Seon Mi Jo, Seoul, KR;
Jong-Hyun Park, Seoul, KR;
NeuroBiogen Co., Ltd., Seongnam-si, KR;
Abstract
The present disclosure relates to an α-aminoamide derivative compound and a pharmaceutical composition containing the same. According to various embodiments of the present disclosure, provided is a therapeutic agent which can overcome the disadvantages of existing drugs used as a MAO-B inhibitor and, specifically, reversibly inhibits MAO-B through a non-covalent bond so as to alleviate or eliminate the side effects of the existing drugs which exhibit a therapeutic effect by irreversibly acting via a covalent bond with MAO-B. Particularly, a new compound having superior stability and efficacy compared to the existing reversible MAO-B inhibitors may be provided.